JP2009501801A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009501801A5 JP2009501801A5 JP2008522937A JP2008522937A JP2009501801A5 JP 2009501801 A5 JP2009501801 A5 JP 2009501801A5 JP 2008522937 A JP2008522937 A JP 2008522937A JP 2008522937 A JP2008522937 A JP 2008522937A JP 2009501801 A5 JP2009501801 A5 JP 2009501801A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- ibuprofen
- famotidine
- oral dosage
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006186 oral dosage form Substances 0.000 claims 15
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 14
- 229960001680 ibuprofen Drugs 0.000 claims 14
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 claims 10
- 229960001596 famotidine Drugs 0.000 claims 10
- 239000002552 dosage form Substances 0.000 claims 5
- AULFVKUUIUIWQU-UHFFFAOYSA-N 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-n'-sulfamoylpropanimidamide;2-[4-(2-methylpropyl)phenyl]propanoic acid Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1.NC(N)=NC1=NC(CSCC\C(N)=N\S(N)(=O)=O)=CS1 AULFVKUUIUIWQU-UHFFFAOYSA-N 0.000 claims 3
- 208000002193 Pain Diseases 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 230000002496 gastric effect Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 208000005171 Dysmenorrhea Diseases 0.000 claims 1
- 206010013935 Dysmenorrhoea Diseases 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 208000038016 acute inflammation Diseases 0.000 claims 1
- 230000006022 acute inflammation Effects 0.000 claims 1
- 208000005298 acute pain Diseases 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 239000008057 potassium phosphate buffer Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70048105P | 2005-07-18 | 2005-07-18 | |
| PCT/US2006/028075 WO2007012019A2 (en) | 2005-07-18 | 2006-07-18 | Medicaments containing famotidine and ibuprofen and administration of same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009501801A JP2009501801A (ja) | 2009-01-22 |
| JP2009501801A5 true JP2009501801A5 (OSRAM) | 2009-08-27 |
Family
ID=37669550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008522937A Pending JP2009501801A (ja) | 2005-07-18 | 2006-07-18 | イブプロフェンとファモチジンとを含有する医薬およびその投与 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20070043097A1 (OSRAM) |
| EP (1) | EP1919288A4 (OSRAM) |
| JP (1) | JP2009501801A (OSRAM) |
| CN (1) | CN101257800B (OSRAM) |
| CA (1) | CA2615496C (OSRAM) |
| IL (1) | IL188732A (OSRAM) |
| NZ (1) | NZ565846A (OSRAM) |
| WO (2) | WO2007012019A2 (OSRAM) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3516632B2 (ja) | 2000-04-27 | 2004-04-05 | オリジン電気株式会社 | 光ディスク基板の貼り合わせ方法及び装置 |
| US20080020040A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Unit dose form for administration of ibuprofen |
| US8067451B2 (en) | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
| US20080021078A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Methods and medicaments for administration of ibuprofen |
| US8067033B2 (en) | 2007-11-30 | 2011-11-29 | Horizon Pharma Usa, Inc. | Stable compositions of famotidine and ibuprofen |
| CA2657928C (en) * | 2006-07-18 | 2014-12-02 | Horizon Therapeutics, Inc. | Methods and medicaments for administration of ibuprofen |
| US20150224056A1 (en) * | 2006-07-18 | 2015-08-13 | Horizon Pharma Usa, Inc. | Pharmaceutical compositions of ibuprofen and famotidine |
| WO2008027963A2 (en) * | 2006-08-31 | 2008-03-06 | Horizon Therapeutics, Inc. | Nsaid dose unit formulations with h2-receptor antagonists and methods of use |
| WO2008091957A2 (en) * | 2007-01-24 | 2008-07-31 | Horizon Therapeutics, Inc. | Pharmaceutical compositions containing famotidine and ibuprofen and having improved content uniformity |
| CA2930063C (en) | 2008-01-04 | 2017-01-31 | Schabar Research Associates Llc | Unit oral solid dose compositions composed of naproxen sodium and nizatidine |
| US9629809B2 (en) | 2008-07-21 | 2017-04-25 | Si Group, Inc. | High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
| BRPI0916344A2 (pt) * | 2008-07-21 | 2020-07-21 | Albemarle Corporation | grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes |
| WO2012003181A2 (en) * | 2010-07-02 | 2012-01-05 | Fmc Corporation | Solid forms |
| WO2013054352A1 (en) | 2011-08-17 | 2013-04-18 | Cadila Healthcare Limited | Pharmaceutical compositions of ibuprofen and famotidine |
| CN102247371A (zh) * | 2011-08-19 | 2011-11-23 | 北京阜康仁生物制药科技有限公司 | 一种以布洛芬和拉呋替丁为活性成分的药物组合物 |
| CN103083314A (zh) * | 2011-10-28 | 2013-05-08 | 四川大学 | 具有胃肠道保护作用的复方布洛芬 |
| WO2015163832A1 (en) | 2014-04-25 | 2015-10-29 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | An ibuprofen and famotidine combined composition having improved stability |
| CN108366982A (zh) * | 2015-10-30 | 2018-08-03 | 癌症预防制药股份有限公司 | 依氟鸟氨酸和舒林酸，固定剂量的组合制剂 |
| IL298196A (en) | 2017-02-17 | 2023-01-01 | Eidos Therapeutics Inc | Processes for preparing ag-10, its intermediates, and salts thereof |
| KR20200135996A (ko) | 2018-03-23 | 2020-12-04 | 에이도스 테라퓨틱스, 인코포레이티드 | Ag10을 사용하여 ttr 아밀로이드증을 치료하는 방법 |
| MA53238A (fr) * | 2018-08-17 | 2022-04-13 | Eidos Therapeutics Inc | Formules d'ag10 |
| US11324727B2 (en) | 2020-07-15 | 2022-05-10 | Schabar Research Associates, Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
| IL299845A (en) | 2020-07-15 | 2023-03-01 | Schabar Res Associates Llc | Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn |
| AU2022244333A1 (en) * | 2021-03-24 | 2023-11-09 | Kenvue Brands Llc | A pharmaceutical composition comprising famotidine |
| US12303604B1 (en) | 2024-10-16 | 2025-05-20 | Currax Pharmaceuticals Llc | Pharmaceutical formulations comprising naltrexone and/or bupropion |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6056143B2 (ja) * | 1979-08-02 | 1985-12-09 | 山之内製薬株式会社 | アミジン誘導体ならびにその製造法 |
| US4543370A (en) | 1979-11-29 | 1985-09-24 | Colorcon, Inc. | Dry edible film coating composition, method and coating form |
| US5037815A (en) * | 1986-03-04 | 1991-08-06 | Bristol-Myers Squibb Co. | Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers |
| HU196775B (en) * | 1986-08-05 | 1989-01-30 | Richter Gedeon Vegyeszet | Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances |
| US5204118A (en) * | 1989-11-02 | 1993-04-20 | Mcneil-Ppc, Inc. | Pharmaceutical compositions and methods for treating the symptoms of overindulgence |
| JP2542122B2 (ja) * | 1990-04-18 | 1996-10-09 | 旭化成工業株式会社 | 球状核、球形顆粒およびその製造方法 |
| EP0452862B1 (en) * | 1990-04-18 | 1995-07-19 | Asahi Kasei Kogyo Kabushiki Kaisha | Spherical seed cores, spherical granules and process for production thereof |
| ES2148175T3 (es) * | 1991-05-13 | 2000-10-16 | Boots Co Plc | Composicion farmaceutica que contiene una sal de ibuprofeno. |
| EP0550083B1 (en) * | 1991-12-06 | 1999-03-24 | Glaxo Group Limited | Medicaments for treating inflammatory conditions or for analgesia containing a NSAID and ranitidine bismuth citrate |
| JPH08502254A (ja) * | 1992-09-29 | 1996-03-12 | メルク エンド カンパニー インコーポレーテッド | イブプロフェン−ｈ▲下２▼拮抗薬配合物 |
| ATE180668T1 (de) * | 1992-12-01 | 1999-06-15 | Spirig Ag | S(+)-ibuprofen enthaltende arzneimittel |
| US5496836A (en) * | 1994-05-05 | 1996-03-05 | Mount Sinai School Of Medicine Of The City University Of New York | Use of famotidine and related compounds in the treatment of movement disorders |
| ES2082723B1 (es) * | 1994-07-20 | 1996-10-01 | Lilly Sa | Formulacion farmaceutica de fluoxetina en forma dispersable. |
| DE19509805A1 (de) * | 1995-03-21 | 1996-09-26 | Basf Ag | Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica |
| US5854267A (en) * | 1995-06-02 | 1998-12-29 | Merck & Co., Inc. | Method for preventing heartburn |
| SE9600070D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
| SI1208847T1 (sl) * | 1996-07-30 | 2007-06-30 | Novartis Ag | Farmacevtski sestavki za zdravljenje stanj zavračanja transplantatov in avtoimunskih ali vnetnih stanj |
| US5997905A (en) * | 1998-09-04 | 1999-12-07 | Mcneil-Ppc | Preparation of pharmaceutically active particles |
| FR2785539B1 (fr) * | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | Particules enrobees d'ibuprofene cristallin granule |
| EP1140066A4 (en) * | 1998-11-17 | 2005-11-09 | Nitromed Inc | NITRO- AND NITROSYL COMPOUNDS OF H2 RECEPTOR ANTAGONISTS, COMPOSITIONS AND THEIR USES OF USE |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US20030178031A1 (en) * | 1999-05-07 | 2003-09-25 | Du Pen, Inc. | Method for cancer pain treatment |
| BR0016482A (pt) * | 1999-12-06 | 2002-12-24 | Mendell Co Inc Edward | Método para melhorar a compressibilidade de um superdesintegrante, obter um complexo de preparado de droga superdesintegrante altamente compatìvel , superdesintegrante aumentado e sua forma de dosagem sólida |
| MXPA03011017A (es) * | 2001-06-01 | 2005-04-29 | Pozen Inc | Composiciones farmaceuticas para la entrega coordinada de nsaids. |
| GB0124459D0 (en) * | 2001-10-11 | 2001-12-05 | Novartis Ag | Organic compounds |
| US7169809B2 (en) * | 2003-03-05 | 2007-01-30 | Merck Frosst Company | Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors |
| US20050053655A1 (en) * | 2003-09-05 | 2005-03-10 | Pharmaceutical Industry Technology And Development Center | Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same |
| EP1691789B1 (en) * | 2003-11-25 | 2017-12-20 | SmithKline Beecham (Cork) Limited | Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
| US20050163847A1 (en) * | 2004-01-21 | 2005-07-28 | Andrx Pharmaceuticals, Llc | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug |
| AU2005213472A1 (en) * | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
| US20060177504A1 (en) * | 2005-02-08 | 2006-08-10 | Renjit Sundharadas | Combination pain medication |
| CA2511158A1 (en) * | 2005-06-29 | 2006-12-29 | Medical Futures Inc. | Medicated gumstick for treatment in anti-inflammatory conditions and prophylaxis against nsaid gastropathy |
| US8067451B2 (en) * | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
| US20080021078A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Methods and medicaments for administration of ibuprofen |
-
2006
- 2006-07-18 CN CN2006800324428A patent/CN101257800B/zh not_active Expired - Fee Related
- 2006-07-18 US US11/489,705 patent/US20070043097A1/en not_active Abandoned
- 2006-07-18 WO PCT/US2006/028075 patent/WO2007012019A2/en not_active Ceased
- 2006-07-18 EP EP06800140A patent/EP1919288A4/en not_active Withdrawn
- 2006-07-18 WO PCT/US2006/028078 patent/WO2007012022A2/en not_active Ceased
- 2006-07-18 US US11/489,275 patent/US20070043096A1/en not_active Abandoned
- 2006-07-18 CA CA2615496A patent/CA2615496C/en not_active Expired - Fee Related
- 2006-07-18 NZ NZ565846A patent/NZ565846A/en not_active IP Right Cessation
- 2006-07-18 JP JP2008522937A patent/JP2009501801A/ja active Pending
-
2008
- 2008-01-13 IL IL188732A patent/IL188732A/en not_active IP Right Cessation
-
2013
- 2013-02-15 US US13/769,196 patent/US20140066485A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009501801A5 (OSRAM) | ||
| RU2011110765A (ru) | Фармацевтическая композиция энтакапона или его солей пролонгрированного высвобождения | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP3806427B2 (ja) | 新規鎮痛剤 | |
| JP5970189B2 (ja) | 医薬調製物 | |
| JP2018507243A5 (OSRAM) | ||
| JP2016164165A5 (OSRAM) | ||
| JP2010522240A (ja) | 炎症を処置するための組成物および方法 | |
| JP2013541583A5 (OSRAM) | ||
| JPS6388122A (ja) | 吸収および作用が速やかなサリンダツクまたはサリンダツクナトリウムと塩基の併用剤 | |
| WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
| JP2006516571A5 (OSRAM) | ||
| JP2005528430A5 (OSRAM) | ||
| JP2020500864A5 (OSRAM) | ||
| JP5403935B2 (ja) | 経口用の慢性疼痛予防または治療剤 | |
| CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
| RU2487707C2 (ru) | Применение парацетамола и ибупрофена в лечении | |
| JP5828609B2 (ja) | 持続性解熱鎮痛消炎剤 | |
| JP2012505830A5 (OSRAM) | ||
| WO2009123206A1 (ja) | 経口医薬組成物 | |
| Zarafonetis | Treatment of scleroderma | |
| JP5712249B2 (ja) | ロキソプロフェン含有経口用組成物 | |
| CN104740112A (zh) | 番茄红素和葡萄籽组合物在制备治疗关节炎药物中的应用 | |
| JP2019529559A5 (OSRAM) | ||
| RU2016144695A (ru) | Комплекс танната ситаглиптина |